- ISIN
- US50015M1099
- CUSIP
- 50015M109
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 4, 2018
Highlights
- EPS (TTM)
- -$4.11
- Gross Profit (TTM)
- -$26.49M
- EBITDA (TTM)
- -$190.85M
- Year Range
- $3.55 - $47.84
- Target Price
- $44.00
- ROA (TTM)
- -61.83%
- ROE (TTM)
- -138.09%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
KOD Performance Chart
Kodiak Sciences Inc. (KOD) is up 31.0% since the beginning of the year. At $37 per share, KOD is trading 23.4% below its 52-week high of $48. Investors who bought $1,000 worth of KOD shares 5 years ago would now be looking at an investment worth $433.
Loading charts...
Returns By Period
Kodiak Sciences Inc. (KOD) has returned 31.01% so far this year and 911.88% over the past 12 months.
Kodiak Sciences Inc.
- 1D
- 1.36%
- 1M
- 1.10%
- YTD
- 31.01%
- 6M
- 28.03%
- 1Y
- 911.88%
- 3Y*
- 71.67%
- 5Y*
- -15.41%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
KOD Monthly Returns History
Based on dividend-adjusted daily data since Oct 4, 2018, KOD's average daily return is +0.30%, while the average monthly return is +6.75%. At this rate, an investment would double in approximately 0.9 years.
Historically, 55% of months were positive and 45% were negative. The best month was Dec 2019 with a return of +143.1%, while the worst month was Feb 2022 at -85.3%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.
On a daily basis, KOD closed higher 50% of trading days. The best single day was Mar 26, 2026 with a return of +74.8%, while the worst single day was Feb 23, 2022 at -80.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.56% | 17.70% | 42.24% | 14.06% | -15.57% | -0.22% | 31.01% | ||||||
| 2025 | -35.68% | -35.78% | -31.75% | 55.44% | -22.02% | 9.71% | 76.27% | 37.49% | 81.08% | 10.72% | 26.79% | 21.67% | 181.01% |
| 2024 | 31.91% | 49.88% | -12.48% | -38.97% | -0.93% | -26.10% | 23.83% | -13.75% | 3.98% | 45.59% | 75.53% | 49.18% | 227.30% |
| 2023 | 12.85% | -19.55% | -4.62% | -29.35% | 35.39% | 16.36% | -56.67% | -26.42% | -18.18% | -19.44% | 66.90% | 25.62% | -57.54% |
| 2022 | -30.76% | -85.28% | -10.65% | -22.02% | 20.27% | 5.52% | 30.24% | 0.60% | -22.68% | -7.24% | 2.79% | -2.98% | -91.55% |
| 2021 | -14.02% | 2.14% | -12.11% | 6.57% | -30.80% | 11.22% | -9.85% | 12.33% | 1.91% | 21.99% | -21.56% | -7.69% | -42.29% |
Benchmark Metrics
Kodiak Sciences Inc. has an annualized alpha of 70.82%, beta of 1.46, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since October 04, 2018.
- This stock captured 259.29% of S&P 500 Index gains and 175.21% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 70.82%
- Beta
- 1.46
- R²
- 0.08
- Upside Capture
- 259.29%
- Downside Capture
- 175.21%
Return for Risk
Risk / Return Rank
KOD ranks 99 for risk / return — in the top 99% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Kodiak Sciences Inc. (KOD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KOD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.75 | ||
| Sortino ratioReturn per unit of downside risk | +2.81 | ||
| Omega ratioGain probability vs. loss probability | 1.64 | 1.37 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 25.42 | 2.78 | +22.64 |
| Martin ratioReturn relative to average drawdown | 60.51 | 12.44 | +48.07 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Kodiak Sciences Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Kodiak Sciences Inc. was 99.15%, occurring on Oct 25, 2023. The portfolio has not yet recovered.
The current Kodiak Sciences Inc. drawdown is 77.73%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -99.15%Oct 2023 | 2y 9mo | — | 5y 5moJan 2021 - now |
COVID crash2020 | -50.19%Mar 2020 | 2mo 23d | 7mo 5d | 9mo 28dDec 2019 - Oct 2020 |
Rate-hike selloffLate 2018 | -41.42%Dec 2018 | 2mo 14d | 5mo 21d | 8mo 5dOct 2018 - Jun 2019 |
2019 bear market2019 | -31.60%Aug 2019 | 23d | 29d | 1mo 22dJul 2019 - Sep 2019 |
2019 bear market2019 | -20.89%Oct 2019 | 17d | 7d | 24dSep 2019 - Oct 2019 |
Drawdown Indicators
| KOD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.15% | -56.78% | -42.37% |
Max Drawdown (1Y)Largest decline over 1 year | -36.24% | -9.10% | -27.14% |
Max Drawdown (3Y)Largest decline over 3 years | -81.31% | -18.90% | -62.41% |
Max Drawdown (5Y)Largest decline over 5 years | -98.91% | -25.43% | -73.48% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -77.73% | -1.80% | -75.93% |
Average DrawdownAverage peak-to-trough decline | -64.00% | -10.71% | -53.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.19% | 2.03% | +13.16% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Kodiak Sciences Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Kodiak Sciences Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with KOD
Add Kodiak Sciences Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with KOD